Presents

Jeffery Struewing, M.D., M.S., Epidemiologist, Office of Population Genomics, National Human Genome Research Institute

Steve Latham, Ph.D., J.D., Director, Center for Health Law & Policy, Quinnipiac University School of Law

Errol Norwitz, M.D., Ph.D., Co-Director, Maternal-Fetal Medicine, Yale University School of Medicine

Paul Pescatello, J.D., Ph.D., CEO/President, CT United for Research Excellence, Moderator

Biobanks are large biological repositories, and the information derived from their contents is used to discern the genetic and environmental factors that cause disease. Some biobanks are more focused in scope, created to study a specific disease. Other biobanks, such as national biobanks that exist in other countries, and under recent discussion in the U.S., are used to identify the multiple genes that interact to cause common chronic diseases. These latter biobanks require a large number of donated samples, and, consequently, often require a centralized infrastructure and government coordination. Our panel of experts will discuss the promise and regulatory challenges of biobanks of varying scope and magnitude, at the international, national, and more regional level.

To register, email [email protected] or call 860 509-7218. For more information, contact Beverly Burke, M.S.W., at 860 509-7122, or at [email protected]